Verastem (VSTM) Shares Outstanding (Weighted Average) (2011 - 2026)

Verastem (VSTM) recorded quarterly Shares Outstanding (Weighted Average) of $98.3 million in Q1 2026, up 1066.09% quarter-over-quarter from $8.4 million in Q4 2025, and up 81.44% on a YoY basis from $54.2 million in Q1 2025.

Verastem (VSTM) Shares Outstanding (Weighted Average) (2011 - 2026) Analysis & Trends

Verastem's Shares Outstanding (Weighted Average) history runs 16 years deep, the most recent figure standing at $98.3 million for Q1 2026.

  • In Q1 2026, Shares Outstanding (Weighted Average) rose 81.44% year-over-year to $98.3 million; the TTM figure through Mar 2026 stood at $98.3 million (up 81.44% YoY), while the FY2025 annual figure was $8.4 million, down 53.39% from the prior year.
  • Shares Outstanding (Weighted Average) was $98.3 million for Q1 2026 at Verastem, up from $8.4 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $186.3 million in Q1 2022 to a low of $8.4 million in Q4 2025.
  • Historically, Shares Outstanding (Weighted Average) has averaged $41.5 million across 5 years, with a median of $22.1 million in 2023.
  • The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Weighted Average) tumbled 91.02% in 2023, then soared 146.38% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $16.1 million in 2022, then surged by 36.66% to $22.1 million in 2023, then dropped by 18.0% to $18.1 million in 2024, then sank by 53.39% to $8.4 million in 2025, then soared by 1066.09% to $98.3 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $98.3 million (Q1 2026), $8.4 million (Q4 2025), and $64.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 185,491.37 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 400.00 Bn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 100.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 417.01 Bn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 254.10 Mn
9 Abivax 91.96 Bn 91.96 Bn - 928.40 Mn
10 Verastem 407.42 Mn 225.74 Mn 15.90 Mn 98.29 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 98.29 Mn
Dec 31, 2025 8.43 Mn
Sep 30, 2025 64.56 Mn
Jun 30, 2025 66.14 Mn
Mar 31, 2025 54.17 Mn
Dec 31, 2024 18.08 Mn
Sep 30, 2024 31.35 Mn
Jun 30, 2024 26.85 Mn
Mar 31, 2024 26.83 Mn
Dec 31, 2023 22.05 Mn
Sep 30, 2023 20.45 Mn
Jun 30, 2023 17.73 Mn
Mar 31, 2023 16.72 Mn
Dec 31, 2022 16.14 Mn
Sep 30, 2022 16.43 Mn
Jun 30, 2022 15.53 Mn
Mar 31, 2022 186.26 Mn
Dec 31, 2021 14.54 Mn
Sep 30, 2021 179.86 Mn
Jun 30, 2021 171.99 Mn